In vitro and in vivo immunomodulatory activity of an N-9 arginyl hypoxanthine derivative (PCF-39)
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (6) , 659-667
- https://doi.org/10.1016/0192-0561(87)90036-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Interferon‐activated tumor inhibition in vivo. Small amounts of interferon‐gamma inhibit tumor growth by eliciting host systemic immunoreactivityInternational Journal of Cancer, 1986
- Sensory neuropeptides (substance P) and 4–11 SP enhance human neutrophils chemiluminescence; the role of L-arginineInternational Journal of Immunopharmacology, 1986
- Immunomodulatory properties of A N-9 arginil hypoxantine derivative (PCF 39)International Journal of Immunopharmacology, 1985
- The generation of culture activated killer cells (AK) is interleukin‐2‐dependent and requires self‐ia recognitionInternational Journal of Cancer, 1985
- In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.The Journal of Immunology, 1984
- TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinomaClinical & Experimental Metastasis, 1983
- In vitro detection of cell‐mediated immunity to individual tumor‐specific antigens of chemically induced BALB/c fibrosarcomasInternational Journal of Cancer, 1983
- DISTINCT ALLOANTIGENS TRIGGER PROLIFERATIVE OR NONPROLIFERATIVE T LYMPHOCYTE ACTIVATION IN CBA/N, CBA/J, AND C3H MICETransplantation, 1982
- Natural Cell-Mediated ImmunityPublished by Elsevier ,1978
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973